Search research articles
Contact Us
Filters
Showing results (81-90 of 130) with videos related to
Page
of 13
Sort By:
Leukemia
|
March 6, 2013
Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis
F J Giles, M J Mauro, F Hong, et al.
Leukemia & Lymphoma
|
December 29, 1999
Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II study
F J Giles, S M O'Brien, V Santini, et al.
Bone Marrow Transplantation
|
March 14, 2003
Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia
A-M Tsimberidou, J Medina, M Earl, et al.
Cancer
|
December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients
S Sacchi, H M Kantarjian, S O'Brien, et al.
Thorax
|
October 30, 2007
Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoma
M P Kennedy, C A Jimenez, J F Bruzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2017
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives
R Costa, B A Carneiro, D A Wainwright, et al.
Leukemia & Lymphoma
|
December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia
S Sacchi, H M Kantarjian, E J Freireich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 15, 2010
ELR510444, a novel microtubule disruptor with multiple mechanisms of action
A L Risinger, C D Westbrook, A Encinas, et al.
Leukemia
|
July 29, 2005
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias
H M Amin, Y Yang, Y Shen, et al.
Cancer Genetics and Cytogenetics
|
July 15, 1995
Burkitt translocation (8;22)(q24;q11) in a patient with multiple myeloma
R M Look, S W Lim, R R Schreck, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 130) with videos related to
Sort By:
Page
of 13
Leukemia
|
March 6, 2013
Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis
F J Giles, M J Mauro, F Hong, et al.
Leukemia & Lymphoma
|
December 29, 1999
Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II study
F J Giles, S M O'Brien, V Santini, et al.
Bone Marrow Transplantation
|
March 14, 2003
Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia
A-M Tsimberidou, J Medina, M Earl, et al.
Cancer
|
December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients
S Sacchi, H M Kantarjian, S O'Brien, et al.
Thorax
|
October 30, 2007
Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoma
M P Kennedy, C A Jimenez, J F Bruzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2017
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives
R Costa, B A Carneiro, D A Wainwright, et al.
Leukemia & Lymphoma
|
December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia
S Sacchi, H M Kantarjian, E J Freireich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 15, 2010
ELR510444, a novel microtubule disruptor with multiple mechanisms of action
A L Risinger, C D Westbrook, A Encinas, et al.
Leukemia
|
July 29, 2005
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias
H M Amin, Y Yang, Y Shen, et al.
Cancer Genetics and Cytogenetics
|
July 15, 1995
Burkitt translocation (8;22)(q24;q11) in a patient with multiple myeloma
R M Look, S W Lim, R R Schreck, et al.
Page
of 13